Immunosuppressives aid survival in late ANCA-associated vasculitis

People diagnosed with ANCA-associated vasculitis (AAV) at age 75 or older may show more inflammation, higher rates of kidney involvement, or higher mortality than younger-onset patients based on their AAV type, a study in Japan finds. But immunosuppressive treatment plus standard corticosteroids appears to be more effective than corticosteroids…

As I look back on Vasculitis Awareness Month in May, I find myself grappling with a complex wave of emotions. On one hand, there’s undeniable excitement and a spark of validation. For once, the spotlight is on our disease, which usually lurks in the shadows. ANCA-associated vasculitis is a…

Andrea Merriam, left, and Sarah Jones attend the World Parkinson Congress in Kyoto, Japan, the year before Jones began experiencing EGPA symptoms. (Courtesy of Andrea Merriam) This is Andrea Merriam’s story: The following is a conversation between ANCA Vasculitis News columnist Sarah Jones and her colleague and friend, Andrea…

An imaging test that can make detailed pictures of the heart can detect scar tissue buildup in the heart muscle of adults with ANCA-associated vasculitis (AAV), even if they’re not having disease symptoms, a review study shows. “Incorporating cMRI [cardiac MRI] into routine evaluations could improve the detection and…

Janessa Kaneaster’s 7-year-old daughter, Kaylee, who has ANCA vasculitis, takes a break for a picnic lunch. (Courtesy of Janessa Kaneaster) This is Janessa Kaneaster’s story: When your 7-year-old gets diagnosed with something as rare and complicated as ANCA vasculitis, everything shifts. It’s not loud panic — it’s more…

Infections are a leading cause of early death in adults with ANCA-associated vasculitis (AAV), being most common in the first year after a diagnosis when treatment with immunosuppressive medications is most intense, a single-center study in Australia suggests. Hospitalizations due to infections tended to decrease after a dedicated vasculitis…

Heather Fish takes in the fresh air of the coast after seeing improvements following treatment for her EGPA. (Photos courtesy of Heather Fish) This is Heather Fish’s story: It was a terrible time in so many ways. My husband had cancer in a place that meant he could no…

Adults with active eosinophilic granulomatosis with polyangiitis (EGPA), a rare type of ANCA-associated vasculitis (AAV), report improvements in health-related quality of life as early as one week after starting treatment with Nucala (mepolizumab). These are the findings of a multicenter European study that evaluated the effects of Nucala…

Steven Chetham runs a 5K race in Boulder, Colorado, in September 2024. (Photos courtesy of Steven Chetham) This is Steven Chetham’s story: I was diagnosed with granulomatosis with polyangiitis (GPA) in September 2023. Everyone’s journey with ANCA-associated vasculitis (AAV) is different, but we do have many…